Last reviewed · How we verify

NCT04847258

Rate of Non-copers to Non-surgical ACL Treatment After 3 Months of Rehabilitation

Recruiting now Last updated 24 June 2025
What this trial tests

trial testing Standard rehabilitation in Anterior Cruciate Ligament Injuries in 357 participants. Currently enrolling.

Timeline
19 March 2021
Primary endpoint
30 June 2027
30 June 2028

Quick facts

Lead sponsorVejle Hospital
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment357
Start date19 March 2021
Primary completion30 June 2027
Estimated completion30 June 2028
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Vejle Hospital

Who can join

Adults 18 to 49, any sex, with Anterior Cruciate Ligament Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim is to determine the sensitivity and specificity of a screening tool to identify patients who undergo ACL reconstruction (non-copers) after 3 months of standard rehabilitation following an anterior Cruciate ligament (ACL) injury.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Standard rehabilitation

Trials testing the same drug.

Other recruiting trials for Anterior Cruciate Ligament Injuries

Currently open trials in the same condition.

Other Vejle Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04847258.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing